RPRX
Royalty Pharma plc · Healthcare
EVP, Research, Investments Marshall Urist sold $1.6M of Royalty Pharma plc
Sold$1,627,815
$39.15Price
41,576Shares
−18%Stake
What RPRX did after the filing
- The stock from Wed, Dec 10 open, $37.88
- +5.8%
- S&P 500, same days
- +2.3%
Measured over 30 trading days, to the Jan 26 close.
Traded Fri, Dec 5. Filed Tue, Dec 9, 5:00 PM ET, after the close. Returns use the Dec 10 open and the Jan 26 close. Not investment advice.